GA-CYBLE
5.4.2021 23:56:07 CEST | Business Wire | Press release
Cyble, a global cyber intelligence firm specializing in providing early warning intelligence on cyber threats, announced today that it has raised a $4M seed financing round led by Blackbird Ventures and Spider Capital, with participation from Xoogler Ventures, Picus Capital, and Cathexis Ventures.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210405005474/en/
The funding comes as Cyble graduates from Y Combinator, which accepted Cyble into its Winter 2021 (W21) cohort and provided pre-seed funding in January of this year. These investments demonstrate the continued trust that investors and clients have in Cyble.
Cyble has made huge progress over the last year. "We started this company with an ambitious goal: to equip organizations with real-time visibility into vulnerabilities in the cyber landscape and help safeguard their businesses. As we continue to deliver what modern organizations need, the seed funding reaffirms our strategy and vision. It will enable Cyble to onboard resources and scale our SaaS platform, Cyble Vision, in lock step with our rapidly growing client base," says Manish Chachada, COO and Co-founder of Cyble.
Michael Neril of Spider Capital noted: “We are excited to partner with Cyble as they scale their revolutionary SaaS platform focused on dark web monitoring. The founding team have deep domain expertise in this space, and we look forward to seeing their product gain further traction in this market.”
Tom Humphrey of Blackbird Ventures noted: "The Cyble team are wild hearts on a mission. We are struck by the progress they have achieved to date and believe they are only just getting started. Dark web monitoring and mitigation capabilities are front of mind for modern organizations and the market is growing rapidly."
Cyble has also signed a partnership with Aditya Birla Group Innovation Fund to jointly identify and engage in the pilot for application and use of Cyble’s offerings at Aditya Birla Group (ABG). Headquartered in India, the Aditya Birla Group is a 150 years old multi-business, multi-national conglomerate. With 45B USD in global revenues, the ABG businesses are leaders in their respective industry spaces. “Developing a system of early warning signals for threats to corporate assets arising from the dark web is a new frontier for our cyber security and is an area of high priority for ABG. We are proud to partner with the Cyble Team to take the lead in testing, refining, adopting and co-innovating new-age cyber security technologies with them,” said Shrenik M Khasgiwala of ABG Innovation Fund.
"We're really excited about what the next 18 to 24 months hold for Cyble," says Beenu Arora, CEO and Co-founder of Cyble. "It's our mission to empower organizations to fortify against increasingly sophisticated cyber threats. We are extremely excited to welcome our new partners and have the additional resources to accelerate our product roadmap and better arm our clients with the tools they require to fight cybercrime."
About Cyble
Cyble
is a global threat intelligence SaaS provider that helps enterprises protect themselves from cybercrimes and exposure in the darkweb. Cyble’s prime focus is to provide organizations with real-time visibility into their digital risk footprint. Backed by Y Combinator as part of the 2021 winter cohort, Cyble has also been recognized by Forbes as one of the top 20 Best Cybersecurity Startups To Watch In 2020. Headquartered in Alpharetta, Georgia, and with offices in Australia, Singapore, and India, Cyble has a global presence. To learn more about Cyble, visit www.cyble.io
. To learn more about Cyble, visit www.cyble.io
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210405005474/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
